EntityQ2723146· pop 17· linked from 486 articles

acemetacin

Acemetacin is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis, rheumatoid arthritis, lower back pain, and relieving post-operative pain. It is manufactured by Merck KGaA under the tradename Emflex. It is no longer available in the UK (since 2018), however is available in other countries as a prescription-only drug.

Research

156 papers

Acemetacin.2006
Single dose oral acemetacin for acute postoperative pain in adults.The Cochrane database of systematic reviews · 2009
Acemetacin monohydrate.Acta crystallographica. Section C, Crystal structure communications · 2007
Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
Radioiodinated acemetacin loaded niosomes as a dual anticancer therapy.International journal of pharmaceutics · 2022

via PubMed

Article

10 sections

Contents

Medical uses
Contraindications
Adverse effects
Interactions
Pharmacology
Pharmacokinetics
Chemistry
Society and culture
Brand names
References

== Medical uses == Acemetacin has proven effective in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other kinds of rheumatoid inflammation, as well as in post-operative and post-traumatic pain and attack of gout. Application of a single dose of acemetacin for post-operative pain is not well supported by studies.